0001553350-20-000824.txt : 20200902 0001553350-20-000824.hdr.sgml : 20200902 20200902174324 ACCESSION NUMBER: 0001553350-20-000824 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200831 FILED AS OF DATE: 20200902 DATE AS OF CHANGE: 20200902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McNamara Anne M CENTRAL INDEX KEY: 0001793019 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38175 FILM NUMBER: 201157773 MAIL ADDRESS: STREET 1: 276 FIFTH AVENUE STREET 2: SUITE 505 CITY: NEW YORK STATE: NY ZIP: 10001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ASPEN GROUP, INC. CENTRAL INDEX KEY: 0001487198 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-EDUCATIONAL SERVICES [8200] IRS NUMBER: 271933597 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 276 FIFTH AVENUE STREET 2: SUITE 505 CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 646-448-5144 MAIL ADDRESS: STREET 1: 276 FIFTH AVENUE STREET 2: SUITE 505 CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: Elite Nutritional Brands, Inc. DATE OF NAME CHANGE: 20111011 FORMER COMPANY: FORMER CONFORMED NAME: Hidden Ladder, Inc. DATE OF NAME CHANGE: 20100315 4 1 mcnamara4.xml OWNERSHIP DOCUMENT X0306 4 2020-08-31 0 0001487198 ASPEN GROUP, INC. ASPU 0001793019 McNamara Anne M 276 FIFTH AVENUE SUITE 505 NEW YORK NY 10001 0 1 0 0 Chief Nursing Officer Common Stock 2020-08-31 4 M 0 5000 A 10000 D Common Stock 2020-08-31 4 F 0 2220 D 7780 D Common Stock 2020-09-02 4 M 0 12500 A 20280 D Common Stock 2020-09-02 4 F 0 5550 D 14730 D Restricted Stock Units 2020-08-31 4 M 0 5000 0 D Common Stock 5000 45000 D Restricted Stock Units 2020-09-02 4 M 0 12500 0 D Common Stock 12500 32500 D Represents shares of common stock to be issued upon the vesting of restricted stock units ("RSUs") which vest in four years, subject to accelerated vesting upon the stock price closing at certain higher levels. The first target price was met as of August 31, 2020, and the second target price was met on September 2, 2020. See the Form 4 filed on February 5, 2020 for further details on the vesting target prices. The shares were surrendered upon vesting to pay the Reporting Person's estimated applicable federal, state and local income taxes, social security taxes and the additional Medicare surtax. The transactions were exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as they were pre-approved by both the board of directors and the compensation committee of the board of directors of the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs were granted on February 4, 2020 and one-half will fully vest subject to the accelerated vesting on February 4, 2024. /s/ Anne McNamara 2020-09-02